Home LiteratureArticle Details
PMID: 32078086 Published · ppublish English Journal Article Randomized Controlled Trial

Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.

Journal of neuro-oncology ·Vol. 147 ·No. 2 ·2020-04-00 ·页码 451-457

Lester EG, Macklin EA, Plotkin S, Vranceanu AM

Abstract

To examine effects of a virtual mind-body group for adolescents with neurofibromatoses (NF1 and NF2; Resilient Youth with Neurofibromatosis; RY-NF) on multiple resiliency factors against a health education attention control (Health Education for Youth with Neurofibromatosis; HE-NF) using data from a randomized controlled trial. Specifically, our research question was whether adolescents randomized to the RY-NF (versus the HE-NF) would have greater improvements in resiliency factors at post-intervention and whether these gains would be maintained at 6-month follow-up. Adolescents with NF (n = 51; M age 12-17) were randomly assigned to RY-NF (n = 27) or HE-NF (n = 24). Resiliency factors (mindfulness, coping, gratitude, optimism, and social support) were collected at baseline, post-intervention (88%), and 6-month follow-up (82%). Participation in the RY-NF was associated with greater pre-to-post improvements in gratitude (Mdifference = 4.38; 95% CI-0.52-8.23; p = .027) and mindfulness (Mdifference= 9.41; 95% CI 4.40-14.42.; p < .001) compared to HE-NF; improvements sustained at 6 months. There were no group differences on any additional resiliency factors. However, participation in the RY-NF was associated with pre-to-post- improvements in coping (Mdifference= 9.16; 95% CI 2.93-15.39; p = .005), and social support (Mdifference= 6.79; 95% CI 1.96-11.63; p = .007); improvements sustained at 6 months. Participation in the RY-NF resulted in sustained improvement in several resiliency factors. Promoting resiliency may help adolescents successfully navigate challenges associated with NF.

Keywords
Adolescents Mind–body Neurofibromatosis Resilience Videoconferencing
MeSH 主题词
Adaptation, Psychological Adolescent Child Female Follow-Up Studies Humans Male Mindfulness/methods Neurofibromatoses/psychology,therapy Prognosis Quality of Life Resilience, Psychological Telemedicine
作者与单位
共 4 位作者,点击展开单位 / ORCID
Lester Ethan G
Integrated Brain Health Clinical and Research Program, Psychiatry Department, Massachusetts General Hospital, One Bowdoin Square, 1st Floor, Boston, MA, 02114, USA. | Harvard Medical School, One Bowdoin Square, 1st Floor, Boston, MA, 02114, USA.
Macklin Eric A
Harvard Medical School, One Bowdoin Square, 1st Floor, Boston, MA, 02114, USA. | Biostatistics Center, Massachusetts General Hospital, 50 Staniford Street, St 560, Boston, MA, 02114, USA.
Plotkin Scott
Harvard Medical School, One Bowdoin Square, 1st Floor, Boston, MA, 02114, USA. | Neurofibromatosis Clinic, Massachusetts General Hospital, 32 Fruit Street, Yawkey Building 9E, Boston, MA, 02114, USA.
Vranceanu Ana-Maria ORCID
Integrated Brain Health Clinical and Research Program, Psychiatry Department, Massachusetts General Hospital, One Bowdoin Square, 1st Floor, Boston, MA, 02114, USA. avranceanu@mgh.harvard.edu. | Harvard Medical School, One Bowdoin Square, 1st Floor, Boston, MA, 02114, USA. avranceanu@mgh.harvard.edu.
Article Info
Journal
Journal of neuro-oncology
Abbr.
J Neurooncol
ISSN
1573-7373
Corresponding email
Published
2020-04-00
电子出版
2020-00-20
页码
451-457
Language
English
Country/Region
United States
NLM ID
8309335
基金资助
Children's Tumor Foundation · W81XWH-17-1-0121
U.S. Department of Defense · W81XWH1910184
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com